NASDAQ: CODXCo Diagnostics Inc Stock Ownership - Who owns Co Diagnostics?
Insider buying vs selling
Have Co Diagnostics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Richard David Abbott | President | 2025-11-23 | 17,200 | $0.35 | $6.02kSell |
| Brian Lee Brown | Chief Financial Officer | 2025-11-23 | 40,723 | $0.35 | $14.25kSell |
| Dwight H. Egan | Chief Executive Officer | 2025-11-23 | 49,575 | $0.35 | $17.35kSell |
| Richard David Abbott | President | 2025-05-23 | 7,180 | $0.24 | $1.72kSell |
| Brian Lee Brown | Chief Financial Officer | 2025-05-23 | 48,161 | $0.24 | $11.56kSell |
| Dwight H. Egan | Chief Executive Officer | 2025-05-23 | 51,697 | $0.24 | $12.41kSell |
CODX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CODX insiders and whales buy or sell their stock.
CODX Shareholders
What type of owners hold Co Diagnostics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Brent Satterfield | 112.08% | 2,275,000 | $6.37M | Insider |
| America 2030 Capital LLC | 111.83% | 2,269,795 | $6.36M | Insider |
| Vanguard Group Inc | 94.06% | 1,909,122 | $5.35M | Institution |
| Reagents LLC | 86.06% | 1,746,796 | $4.89M | Insider |
| Legends Capital Group LLC | 64.06% | 1,300,344 | $3.64M | Insider |
| Private Advisory Group LLC | 58.22% | 1,181,633 | $3.31M | Institution |
| Dwight H. Egan | 36.86% | 748,252 | $2.10M | Insider |
| Renaissance Technologies LLC | 35.98% | 730,323 | $2.04M | Institution |
| Brian Lee Brown | 29.53% | 599,355 | $1.68M | Insider |
| Geode Capital Management LLC | 22.13% | 449,148 | $1.26M | Institution |
CODX vs Medical Device Stocks
Co Diagnostics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.